Filing Details
- Accession Number:
- 0001127602-11-030617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-29 16:26:56
- Reporting Period:
- 2011-11-28
- Filing Date:
- 2011-11-29
- Accepted Time:
- 2011-11-29 16:26:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 946840 | Viropharma Inc | VPHM | Pharmaceutical Preparations (2834) | 232789550 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398219 | Robert Pietrusko | 730 Stockton Drive Exton PA 19341 | Vp, Regulatory & Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-28 | 19,000 | $9.99 | 22,910 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-11-28 | 19,000 | $23.00 | 3,910 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-11-28 | 19,000 | $0.00 | 19,000 | $9.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 35,000 | 2009-06-13 | 2018-06-13 | No | 4 | M | Direct |
Footnotes
- The options vest in four equal annual installments beginning on the first anniversary date from time of grant.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2011.
Billionaire Hedge Funds
